Medical device firm Ethicon has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Enseal X1 large jaw tissue sealer.
Part of the energy device portfolio, Enseal X1 large jaw tissue sealer is a bipolar device designed for surgeons to use in open procedures such as colectomies and hysterectomies.
The company has developed Enseal technology to provide secure vessel sealing and precise heat management in one device.
The company also produces a range of ultrasonic energy devices based on Harmonic technology.
Ethicon energy global strategic marketing vice president Grace Chung said: "Ethicon remains committed to addressing the critical needs of patients, ensuring they have access to the most effective treatment through continued innovation and product enhancement.
"By providing access to leading-edge technology in advanced bipolar energy, we are giving hospitals the ability to work with a single advanced energy provider and surgeons increased choice and the flexibility to meet a diverse set of clinical needs for their patients and procedures."
In March, Ethicon signed an agreement with Google to advance surgical robotics, in bid to help surgeons, patients and health care systems.
Both firms will use their capabilities, intellectual property and expertise to create a new robotic-assisted surgical platform, to improve health care delivery in the operating room.
Ethicon produces surgical technologies and solutions, including sutures, staplers, energy devices, trocars and hemostats.
The company also produces products for the treatment of medical conditions such as obesity and cancer.